Dr. Roofeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson Ave
New Brunswick, NJ 08901Phone+1 732-235-7217
Education & Training
- University of MichiganFellowship, Rheumatology, 2017 - 2019
- Sidney Kimmel Medical College at Thomas Jefferson University/Christiana Care Health ServicesResidency, Internal Medicine/Pediatrics, 2013 - 2017
- SUNY Upstate Medical UniversityClass of 2013
Certifications & Licensure
- NJ State Medical License 2023 - 2025
- MI State Medical License 2017 - 2023
- DE State Medical License 2013 - 2018
- PA State Medical License 2017 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 158 citationsMedial temporal structures and memory functions in adolescents with heavy cannabis useManzar Ashtari, Brian B. Avants, Laura Cyckowski, Kelly L. Cervellione, David Roofeh
Journal of Psychiatric Research. 2011-08-01 - 10 citationsSystemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi
Rheumatology. 2023-05-02 - 63 citationsSystemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.Dinesh Khanna, Alain Lescoat, David Roofeh, Elana J. Bernstein, Ella A. Kazerooni
Arthritis & Rheumatology. 2021-07-27
Press Mentions
- Tocilizumab Effective for Early SSc-Associated Interstitial Lung DiseaseSeptember 22nd, 2021
- Tocilizumab May Improve Lung Function in Early Systemic SclerosisFebruary 17th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: